tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Immunic (IMUX)
NASDAQ:IMUX
US Market
IMUX
Immunic
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Immunic (IMUX) Stock News & Sentiment

Compare
1,586 Followers
Immunic Approves Equity Plan Amendment at Annual Meeting
Premium
Company Announcements
Immunic Approves Equity Plan Amendment at Annual Meeting
28d ago
8K
IMUX
Immunic Announces $65 Million Public Offering
Premium
Company Announcements
Immunic Announces $65 Million Public Offering
1M ago
8K
IMUX
Immunic Announces Public Offering to Fund Trials
Premium
Company Announcements
Immunic Announces Public Offering to Fund Trials
1M ago
8K
IMUX
Buy Rating Affirmed for Immunic’s Vidofludimus Calcium Due to Promising Phase 2 Results and Strong MS Treatment Potential
Premium
Ratings
Buy Rating Affirmed for Immunic’s Vidofludimus Calcium Due to Promising Phase 2 Results and Strong MS Treatment Potential
2M ago
IMUX
Immunic’s Promising Clinical Data and Strategic Financial Position Justify Buy Rating
Premium
Ratings
Immunic’s Promising Clinical Data and Strategic Financial Position Justify Buy Rating
2M ago
IMUX
Positive Phase 2 Trial Results for VidoCa in PMS Bolster Buy Rating for Immunic
Premium
Ratings
Positive Phase 2 Trial Results for VidoCa in PMS Bolster Buy Rating for Immunic
2M ago
IMUX
Promising Phase 2 Results for Vidofludimus Calcium in Progressive Multiple Sclerosis Highlight Potential for Neuroprotection and Disease Modification
Premium
Ratings
Promising Phase 2 Results for Vidofludimus Calcium in Progressive Multiple Sclerosis Highlight Potential for Neuroprotection and Disease Modification
2M ago
IMUX
More IMUX News >

IMUX News on the Web

Immunic CEO discusses Phase 2 multiple sclerosis study success - ICYMI
Proactive Investors
Neutral
Immunic reveals long-term data supporting potential of MS drug vidofludimus calcium
Proactive Investors
Neutral
Immunic reveals long-term data supporting potential of MS drug vidofludimus calcium
Proactive Investors
Neutral
Immunic Posts Positive Long-Term OLE Data From Phase 2 Trial Of Vidofludimus Calcium In RRMS
rttnews
Neutral
Why Immunic, Inc.’s (IMUX) Stock Is Down 5.56%
AAII
Neutral
Immunic showcases MS drug data at BIO International Convention in Boston - ICYMI
Proactive Investors
Neutral
Why Immunic, Inc.’s (IMUX) Stock Is Down 7.18%
AAII
Neutral
Why Immunic, Inc.’s (IMUX) Stock Is Down 7.35%
AAII
Neutral

News Score - Last 7 Days

Neutral
IMUX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMUX’s Media Buzz Sentiment?
1 articles about IMUX were published this week. In an average week, 2.5 articles are published.
    What is IMUX’s weekly average amount of articles?
    In an average week, 2.5 articles about IMUX are published.
      What is IMUX’s News Sentiment?
      50% of articles about IMUX were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        VRNAVerona Pharma
        PBYIPuma Biotechnology
        ALGNAlign Tech
        AUPHAurinia Pharmaceuticals
        CVSCVS Health
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing